Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NYSTATIN Cause Wrong technique in product usage process? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Wrong technique in product usage process have been filed in association with NYSTATIN (Nystatin and Triamcinolone Acetonide). This represents 0.6% of all adverse event reports for NYSTATIN.

12
Reports of Wrong technique in product usage process with NYSTATIN
0.6%
of all NYSTATIN reports
1
Deaths
2
Hospitalizations

How Dangerous Is Wrong technique in product usage process From NYSTATIN?

Of the 12 reports, 1 (8.3%) resulted in death, 2 (16.7%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NYSTATIN. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does NYSTATIN Cause?

Drug ineffective (330) Off label use (149) Dyspnoea (148) Candida infection (145) Nausea (120) Rash (120) Drug hypersensitivity (102) Cough (91) Asthma (90) Condition aggravated (90)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which NYSTATIN Alternatives Have Lower Wrong technique in product usage process Risk?

NYSTATIN vs NYSTATIN\TRIAMCINOLONE ACETONIDE NYSTATIN vs OBETICHOLIC ACID NYSTATIN vs OBINUTUZUMAB NYSTATIN vs OCELLA NYSTATIN vs OCRELIZUMAB

Related Pages

NYSTATIN Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process NYSTATIN Demographics